ChronoScale Holdings Corporation is a Dallas, Texas-based developer of a compute platform purpose-built for artificial intelligence (AI) workloads, providing dedicated GPU-accelerated cloud infrastructure. It operates as a subsidiary of Applied Digital Corporation and was renamed from ChronoScale Corporation in July 2026.
Because the company is newly public, analyst coverage is thin. Two current, attributable targets form the basis of this analysis. Northland Securities analyst Nehal Chokshi initiated coverage with an Outperform rating and a $32 price target in mid-September 2026 and reiterated that Buy-equivalent view in early October. Compass Point initiated coverage with a Buy rating and a $25 target on October 16, 2026. Averaging those two figures yields $28.50, the central target used throughout this article. Some aggregators also carry older pre-2026 figures (including a stale lower target), which are excluded here as outdated.
Both current analysts are constructive, but their targets still span $25 to $32, a roughly 28% gap, reflecting genuine uncertainty about how quickly the company can convert AI demand into profitable revenue.
The shares last traded around $11.62, giving the company a market capitalization of roughly $1.69 billion. Reaching $28.50 would therefore require an advance of about 145% — a very large move. The stock is also down roughly 60% from its 52-week high of $30, having traded as low as $3.50 over the past year.
The path to the target would depend on a meaningful re-rating of the business. Revenue over the trailing twelve months is approximately $96 million, but the company remains deeply unprofitable, with negative EPS (earnings per share) and a price-to-sales ratio near 17x. That is a demanding valuation for a loss-making, early-stage operator, meaning the shares would need sustained evidence of revenue acceleration and improving unit economics to support a move of this magnitude.
The most durable reference points are the 52-week extremes. The $30 area, near the prior high, is the primary resistance level and sits just above the $28.50 target — meaning the target itself is anchored near a meaningful overhead zone. On the downside, the stock recently found footing in the low-to-mid $10s after a multi-month slide, a zone that now serves as near-term support. A sustained close back above roughly $15–$16 would mark an early step toward repairing the longer-term downtrend.
Analyst price targets typically reflect a roughly 12-month research horizon, though the exact horizon is not disclosed for either initiating report. Investors should watch quarterly results, guidance, and any commentary on GPU capacity deployments, customer contracts, and the company's relationship with Applied Digital. Given the cash-burn profile, balance-sheet updates and any capital-raising activity are equally important. Broad AI-sector sentiment and interest-rate expectations, which influence how richly unprofitable growth companies are valued, also matter.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile, thinly covered name like CHRN, this kind of automated monitoring can help traders discover opportunities, track positions, and spot shifting trends more efficiently than manual screening. Traders interested in a systematic view of daily momentum may find these signals a useful complement to traditional research.
The question of whether ChronoScale Holdings can reach $28.50 hinges on an unusually large — roughly 145% — advance from current levels. The target is the average of two bullish, current analyst views ranging from $25 to $32, and it sits just below the stock's prior high near $30, a natural area of resistance. The bull case rests on AI-compute demand and the Applied Digital relationship; the bear case rests on losses, cash burn, and a demanding valuation. With coverage still thin, investors should watch revenue trajectory, contract announcements, and the balance sheet rather than treating the $28.50 figure as a forecast. No outcome is guaranteed, and the target reflects analyst expectations, not a prediction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor tells us that CHRN and KEEL have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHRN and KEEL's prices will move in lockstep.
| Ticker / NAME | Correlation To CHRN | 1D Price Change % | ||
|---|---|---|---|---|
| CHRN | 100% | -5.73% | ||
| KEEL - CHRN | 32% Poorly correlated | -5.80% | ||
| CIFR - CHRN | 32% Poorly correlated | +0.56% | ||
| PENG - CHRN | 32% Poorly correlated | +1.73% | ||
| APLD - CHRN | 29% Poorly correlated | -5.36% | ||
| WYFI - CHRN | 28% Poorly correlated | -0.91% | ||
More | ||||
| Ticker / NAME | Correlation To CHRN | 1D Price Change % |
|---|---|---|
| CHRN | 100% | -5.73% |
| Technology Services category (396 stocks) | 2% Poorly correlated | -0.28% |